Ardelyx
Price & Volume
Stats
See moreOpen | $6.17 |
Previous Close | $6.11 |
Day Range | $6.10-$6.29 |
52W Range | $3.49-$8.40 |
Market Cap | $1.5B |
Shares Short | 23M |
Financials
See moreRevenue (12 Mos) | $427.6M |
Revenue Growth (YoY) | 27.5% |
Gross Profit (12 Mos) | $318.8M |
Diluted EPS | -$0.24 |
News
See moreYahoo Finance • 20 days ago
Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings
Yahoo Finance • 26 days ago
Ardelyx reiterates 2026 guidance as IBSRELA targets $1B in 2029 while advancing ACCEL CIC Phase III enrollment by year-end
Yahoo Finance • 27 days ago
Here are the major earnings after the close Thursday
Yahoo Finance • last month
Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026
About
CEO | Mr. Michael G. Raab |
Address | 400 Fifth Avenue, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 489 |